Stay updated on Pembrolizumab Effects in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Effects in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Effects in Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T14:47:09.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The changes are limited to the site's footer: a new Revision: v3.4.2 tag and updated/removed generic operating-status notices. There is no impact on the study details, eligibility criteria, or data presented on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T01:59:29.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding has been added and the page revision updated to v3.4.1 (replacing v3.4.0).
    Difference
    0.5%
    Check dated 2026-02-03T23:25:19.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Show glossary has been added, and a new 'Last Update Submitted that Met QC Criteria' field is displayed. The old 'Last Update Submitted that met QC Criteria' label, casing of 'No FEAR Act data', and the page revision have been updated to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-27T23:56:38.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Footer shows a minor version update: Revision v3.3.4 added and v3.3.3 removed; no changes to study details, eligibility, or endpoints are apparent.
    Difference
    0.1%
    Check dated 2026-01-14T01:21:23.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added Locations: Ontario (Toronto, Princess Margaret Cancer Centre). Removed Ontario Locations header and HHS Vulnerability Disclosure; updated page revision to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T10:11:02.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Effects in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Effects in Solid Tumors Clinical Trial page.